These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 1778314)

  • 41. Calibration of pertussis toxin BRP batch 1 in a standardised CHO cell-based clustering assay.
    Markey K; Douglas-Bardsley A; Hockley J; Le Tallec D; Costanzo A
    Pharmeur Bio Sci Notes; 2018; 2018():112-123. PubMed ID: 30272557
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An acellular pertussis vaccine in healthy adults: safety and immunogenicity. Pennridge Pediatric Associates.
    Rothstein EP; Anderson EL; Decker MD; Poland GA; Reisinger KS; Blatter MM; Jacobson RM; Mink CA; Gennevois D; Izu AE; Sinangil F; Langenberg AG
    Vaccine; 1999 Aug; 17(23-24):2999-3006. PubMed ID: 10462235
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Proliferative responses to purified and fractionated Bordetella pertussis antigens in mice immunized with whole-cell pertussis vaccine.
    Petersen JW; Andersen P; Ibsen PH; Capiau C; Wachmann CH; Hasløv K; Heron I
    Vaccine; 1993; 11(4):463-72. PubMed ID: 8470432
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acellular pertussis vaccine prepared by a simple extraction and toxoiding procedure.
    Christodoulides M; Sidey FM; Parton R; Stewart-Tull DE
    Vaccine; 1987 Sep; 5(3):199-207. PubMed ID: 2890244
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of the bioactivity of reference preparations for assaying Bordetella pertussis toxin activity in vaccines by the histamine sensitisation and Chinese hamster ovary-cell tests: assessment of validity of expression of activity in terms of protein concentration.
    Xing D; Das RG; Newland P; Corbel M
    Vaccine; 2002 Oct; 20(29-30):3535-42. PubMed ID: 12297399
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative toxicity, protective, histamine sensitizing and leucocytosis promoting activities in mice of Bordetella pertussis culture fluid, bacterial cells and cell extracts.
    Megret F; Fournier JM; Alouf JE
    Med Microbiol Immunol; 1984; 173(4):225-32. PubMed ID: 6096686
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chinese hamster ovary (CHO) cell clustering does not correlate with in vivo histamine-sensitization when measuring residual activity of aldehyde-treated pertussis toxin (PT).
    Kataoka M; Toyoizumi H; Yamamoto A; Ochiai M; Horiuchi Y
    Biologicals; 2002 Dec; 30(4):297-302. PubMed ID: 12421587
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The purification and characterization of an acellular pertussis vaccine.
    Chazono M; Yoshida I; Konobe T; Fukai K
    J Biol Stand; 1988 Apr; 16(2):83-9. PubMed ID: 2897370
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synergistic effect of Bordetella pertussis lymphocytosis-promoting factor on protective activities of isolated Bordetella antigens in mice.
    Robinson A; Irons LI
    Infect Immun; 1983 May; 40(2):523-8. PubMed ID: 6301999
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of a new highly purified pertussis vaccine in infants and children.
    Edwards KM; Bradley RB; Decker MD; Palmer PS; Van Savage J; Taylor JC; Dupont WD; Hager CC; Wright PF
    J Infect Dis; 1989 Nov; 160(5):832-7. PubMed ID: 2809258
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of antibody to leukocytosis-promoting factor hemagglutinin and to filamentous hemagglutinin in immunity to pertussis.
    Sato Y; Izumiya K; Sato H; Cowell JL; Manclark CR
    Infect Immun; 1981 Mar; 31(3):1223-31. PubMed ID: 6262248
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genetically detoxified pertussis toxin (PT-9K/129G): implications for immunization and vaccines.
    Seubert A; D'Oro U; Scarselli M; Pizza M
    Expert Rev Vaccines; 2014 Oct; 13(10):1191-204. PubMed ID: 25183193
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acellular pertussis vaccines containing genetically detoxified pertussis toxin induce long-lasting humoral and cellular responses in adults.
    Di Tommaso A; Bartalini M; Peppoloni S; Podda A; Rappuoli R; De Magistris MT
    Vaccine; 1997 Aug; 15(11):1218-24. PubMed ID: 9286047
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization and detoxification of an easily prepared acellular pertussis vaccine. Antigenic role of the A protomer of pertussis toxin.
    García-Sáinz JA; Romero-Avila MT; Ruíz-Arriaga A; Ruíz-Puente J; Agundis C; Ortiz V; Isibasi A
    Vaccine; 1992; 10(5):341-4. PubMed ID: 1574919
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Characteristics of the biological properties of a cell-free pertussis preparation].
    Zakharova NS; Remova TN; Bazhanova IG; Ozeretskovskaia MN; Shmeleva EI
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Jun; (6):38-43. PubMed ID: 2888247
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunogenicity of glutaraldehyde inactivated pertussis vaccine.
    Gupta RK; Saxena SN; Sharma SB; Ahuja S
    Vaccine; 1990 Dec; 8(6):563-8. PubMed ID: 2128428
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The cell mediated and humoral immune response to vaccination with acellular and whole cell pertussis vaccine in adult humans.
    Petersen JW; Ibsen PH; Bentzon MW; Capiau C; Heron I
    FEMS Microbiol Immunol; 1991 Oct; 3(5):279-87. PubMed ID: 1797049
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Toxicity and potency evaluation of pertussis vaccines.
    Corbel MJ; Xing DK
    Expert Rev Vaccines; 2004 Feb; 3(1):89-101. PubMed ID: 14761246
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Towards replacement of the acellular pertussis vaccine safety test: Comparison of in vitro cytotoxic activity and in vivo activity in mice.
    Wagner LD; Corvette LJ; Ngundi MM; Burns DL
    Vaccine; 2017 Dec; 35(51):7160-7165. PubMed ID: 29122386
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Trial of a new acellular pertussis vaccine in healthy adult volunteers.
    Rutter DA; Ashworth LA; Day A; Funnell S; Lovell F; Robinson A
    Vaccine; 1988 Feb; 6(1):29-32. PubMed ID: 3281387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.